Namsco Corp Ordinary Shares NAMS 深 滬
等待開盤 08-15 09:30:00 美东时间
25.17
-0.590
-2.29%
華盛通- 最 高25.72
- 今 開25.72
- 成交量 65.57万股
- 最 低 24.73
- 昨 收 25.76
- 總市值 28.44亿
- 52周最高 27.29
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 14.06
- 委 比 -37.69%
- 總股本 1.13亿
- 歷史最高 32.88
- 量 比 0.62
- 振 幅 3.84%
- 歷史最低 5.6326
- 每 手 1
- 風險率 4.43%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多RBC Capital Maintains Outperform on NewAmsterdam Pharma Co, Raises Price Target to $39
RBC Capital analyst Leonid Timashev maintains NewAmsterdam Pharma Co (NASDAQ:NAMS) with a Outperform and raises the price target from $38 to $39.
08-07 23:07
NewAmsterdam Pharma Q2 EPS $(0.15) Beats $(0.46) Estimate, Sales $19.145M Beat $2.235M Estimate
NewAmsterdam Pharma (NASDAQ:NAMS) reported quarterly losses of $(0.15) per share which beat the analyst consensus estimate of $(0.46) by 67.39 percent. This is a 63.41 percent increase over losses of $(0.41) per share
08-07 05:51
NewAmsterdam Pharma reports Q2 results
NewAmsterdam Pharma press release (NASDAQ:NAMS): Q2 net loss of $17.47M Revenue of $19.15M (+739.9% Y/Y). More on NewAmsterdam Pharma Seeking Alpha’s Quant Rating on NewAmsterdam Pharma Historical ear...
08-06 19:47
'Biotech Says Its Cholesterol Drug Shows Signs Of Preventing Alzheimer's; NewAmsterdam Pharma Hopes Medicine Born Out Of Big Failures May Have An Unexpected Benefit' - STAT News
https://www.statnews.com/2025/07/30/new-amsterdam-pharma-cholesterol-drug-alzheimers/
07-30 20:25
NewAmsterdam Pharma to Present Alzheimer’s Biomarker Data from BROADWAY Trial at AAIC 2025
New Amsterdam Pharma will host a conference call and webcast on July 30, 2025, at 10:00 a.m. ET to discuss Alzheimer's Disease biomarker data from the BROADWAY clinical trial. Featured speakers include Philip Scheltens, M.D., Ph.D., Kellyann Niotis, M.D., and Nathaniel Chin, M.D.
07-22 12:00
Goldman Sachs Initiates Coverage On NewAmsterdam Pharma Co with Neutral Rating, Announces Price Target of $27
Goldman Sachs analyst Asad Haider initiates coverage on NewAmsterdam Pharma Co (NASDAQ:NAMS) with a Neutral rating and announces Price Target of $27.
07-17 19:21
NewAmsterdam Pharma Updates Employment Agreement with Executive
The latest update is out from NewAmsterdam Pharma Company ( ($NAMS) ). On July ...
07-12 04:48
美股大行评级 | 潜在涨幅40%！华兴资本首予Coinbase买入评级，目标价353.3！Sarepta治疗遭多家机构下调评级和目标价！
美股大行评级 | 潜在涨幅40%！华兴资本首予Coinbase买入评级，目标价353.3！Sarepta治疗遭多家机构下调评级和目标价！
06-18 09:46
美股大行评级 | 潜在涨幅超50%，数十家机构大幅上调甲骨文目标价！
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1140203048973164544.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• Maxim Group：上调Datavault AI(DVLT)评级至"买入"，目标价3美元</p> <p>• 蒙特利尔银行：维持DoubleVerify Holdings(DV)"跑赢大市"评级，目标价从25美元升至26
06-13 09:33
What Analysts Are Saying About NewAmsterdam Pharma Co Stock
4 analysts have shared their evaluations of NewAmsterdam Pharma Co (NASDAQ:NAMS...
06-12 21:01
